Cleveland Clinic physician-scientists are working to better understand the differential responses to medications and other supportive therapies in populations with sepsis and septic shock.
Read MoreRobotically Assisted Tracheobronchoplasty: A Case Study
A 67-year-old with worsening dyspnea and exercise intolerance gets no relief from surgical fundoplication, but his dyspnea improves with temporary placement of a 3D custom silicone Y stent. How best to achieve lasting relief?
Upper Airway Neurostimulation Device for the Treatment of Obstructive Sleep Apnea
For patients with moderate to severe obstructive sleep apnea who are intolerant of traditional CPAP therapy, hypoglossal nerve stimulation may provide welcome QoL improvements
The Importance of a Multidisciplinary Approach to Prone Positioning in ARDS
Cleveland Clinic pulmonologists share a framework for how to implement effective clinical protocols to standardize evaluation and management of complex acute respiratory distress syndrome.
Donor Smoking or Substance Use Alone Should Not Deter Acceptance of Donor Lungs
A database study finds no clinically significant association between lung donor smoking history, pack-years or substance use with primary allograft dysfunction.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Persistent Dyspnea after COVID-19 Infection: Evaluation and Management
Patients with post-COVID-19 dyspnea require a multidisciplinary approach to ascertain the cause of symptoms, which is critical to establishing a diagnosis and treatment plan.
The Chronic Cough Conundrum
Diagnosing the cause of a chronic cough can be challenging and timely, but multidisciplinary collaboration and the development of new treatments are improving the process
Cleveland Clinic’s Respiratory Therapy Training Program
Although the number of respiratory therapy training program enrollees has been declining, the demand for respiratory therapists continues to rise.
Research Links Immune Cell Receptors to Asthma, Inflammatory Lung Disease
A Cleveland Clinic research team has discovered how a protein on the surface of immune system mast cells in the lungs facilitates the cells’ proliferation, contributing to severe inflammation and progression to asthma. Although more research is needed to fully understand mast cell hyperproliferation, inhibiting the surface protein known as MCEMP1 could be a new approach to treating asthma and other inflammatory lung conditions.
How Cleveland Clinic’s Medical Oncology Intensive Care Unit Improves Outcomes
An interdisciplinary team of specialists improves outcomes with effective collaboration, communication and identifying and implementing best practices.
Ten Components of a High-Quality Lung Cancer Screening Program
Finding the balance point between benefit and harm is critical for a successful lung cancer screening program, and these 10 elements can help centers optimize care